Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03490955
Other study ID # 2017-3973
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 6, 2018
Est. completion date November 30, 2019

Study information

Verified date March 2020
Source University of Massachusetts, Amherst
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The objective of this project is to determine the extent to which eating black pepper together with vegetables increase the absorption of carotenoids (a class of important nutrients) in the vegetables such as beta-carotene.


Description:

Black pepper has multiple health-promoting effects, many of which are associated with the relatively high levels of piperine it contains. Piperine can enhance the oral bioavailability of nutraceuticals in foods due to its inhibitory activity on drug metabolizing enzymes such as cytochrome P450 and p-glycoprotein in the gastrointestinal mucosa. This decreases the first-pass metabolism of nutraceuticals thus increasing their levels in the systemic circulation. Numerous studies in both animals and humans have validated the efficacy of piperine in boosting nutraceutical bioavailability. However, most of these studies utilized highly purified sources of both piperine and nutraceuticals, and therefore do not provide direct evidence on the ability of black pepper (used as a spice) to enhance the bioavailability of nutraceuticals in real foods.


Recruitment information / eligibility

Status Completed
Enrollment 16
Est. completion date November 30, 2019
Est. primary completion date June 15, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 30 Years
Eligibility Inclusion Criteria: - 18-30 year old healthy adults Exclusion Criteria: - those who are <18 or >30 years old, have a BMI of <20 or >29 kg/m2, have a weight change >4.5 kg (9.91 pounds) in the past 3 months, exceed exercise activities of a recreational level over the past 3 months, have any diseases, especially intestinal disorders including lipid malabsorption or lactose intolerance, had abnormal liver or kidney function tests. - Those who smoke, consume more than two alcoholic drinks per day, use medication affecting lipid profiles or dietary supplements affecting plasma cholesterol (e.g., Benocol or fiber supplements) will also be excluded. - Additionally, this study excludes menopausal women, those using hormone-based contraceptives, those with abnormal menstrual cycles, and those who are pregnant, lactating or planning to become pregnant.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
salad dressing (canola oil) and black pepper
Subjects will consume a vegetable salad with black pepper and dressing (canola oil) one time in the morning
salad dressing (canola oil)
Subjects will consume a vegetable salad with dressing (canola oil) one time in the morning
black pepper
Subjects will consume a vegetable salad without dressing (canola oil) but with black pepper one time in the morning
salad
Subjects will consume a vegetable salad without dressing (canola oil) and without black pepper one time in the morning
Salad dressing (olive oil) and black pepper
Subjects will consume a vegetable salad with black pepper and dressing (olive oil) one time in the morning
Salad dressing (corn oil) and black pepper
Subjects will consume a vegetable salad with black pepper and dressing (corn oil) one time in the morning
Salad dressing (sunflower oil) and black pepper
Subjects will consume a vegetable salad with black pepper and dressing (sunflower oil) one time in the morning
Salad dressing (flaxseed oil) and black pepper
Subjects will consume a vegetable salad with black pepper and dressing (flaxseed oil) one time in the morning

Locations

Country Name City State
United States Institute for Applied Life Sciences Amherst Massachusetts

Sponsors (1)

Lead Sponsor Collaborator
University of Massachusetts, Amherst

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Determine the level of carotenoids in blood Utilize HPLC to quantify blood levels of carotenoids in subjects consumed test articles 12-16 weeks
See also
  Status Clinical Trial Phase
Completed NCT01185769 - Study of Tocotrienol Absorption and Distribution Under Different Fat Status N/A
Completed NCT03857230 - The Safety and Pharmacokinetics of Primapur and Gonal-f Phase 1
Completed NCT00638079 - Evaluating the Effect of Food on Absorption of Megace ES Phase 1
Completed NCT05650294 - Uptake of an Omega-3 Oil in Healthy Adults N/A
Completed NCT06195319 - Open-label Study of the Absorption, Metabolism, and Excretion of [14C]-Simufilam Following a Single Oral Dose in Healthy Male Subjects Phase 1
Completed NCT04290312 - Absorption and Bioavailability of Major Monoterpenes in Mastiha Oil; a Kinetic Study in Humans. N/A
Suspended NCT00940641 - Assess the Absorption, Distribution, Metabolism and Excretion of AZD7325 After Intravenous and Oral Administration Phase 1
Completed NCT00881062 - Investigate Absorption, Metabolism and Excretion of [14C}-Proellex Following Single Oral Dose in Healthy Females Phase 1
Completed NCT03020680 - Bioavailability of Ubiquinone and Ubiquinol in Older Adults Phase 1